Optic neuritis is inflammation of the optic nerve. Symptoms are usually unilateral, with eye pain and partial or complete vision loss. Diagnosis is primarily clinical. Treatment is directed at the underlying condition; most cases resolve spontaneously.

Etiology

Optic neuritis is most common among adults 20 to 40 yr. Most cases result from demyelinating disease, particularly multiple sclerosis (see Multiple Sclerosis (MS)), in which case there may be recurrences. Optic neuritis is often the presenting manifestation of multiple sclerosis. Other causes include the following:

Symptoms and Signs

The main symptom is vision loss, frequently maximal within 1 or 2 days and varying from a small central or paracentral scotoma to complete blindness. Most patients have mild eye pain, which often feels worse with eye movement.

If the optic disk is swollen, the condition is called papillitis. If the optic disk appears normal, the condition is called retrobulbar neuritis. The most characteristic findings include reduced visual acuity, a visual field deficit, and disturbed color vision (often out of proportion to loss of visual acuity). An afferent pupillary defect is usually detectable if the contralateral eye is unaffected or involved to a lesser degree. Testing of color vision is a useful adjunct. In about two thirds of patients, inflammation is entirely retrobulbar, causing no visible changes in the optic fundus. In the rest, disk hyperemia, edema in or around the disk, vessel engorgement, or a combination is present. A few exudates and hemorrhages may be present near or on the optic disk.

Diagnosis

Clinical evaluation

MRI

Optic neuritis is suspected in patients with characteristic pain and vision loss, particularly if they are young. Neuroimaging, preferably with gadolinium-enhanced MRI, is usually done and may show an enlarged, enhancing optic nerve. MRI may also help diagnose multiple sclerosis. Fluid attenuating inversion recovery (FLAIR) MRI sequences may show typical demyelinating lesions in a periventricular location if optic neuritis is related to demyelination.

Pearls & Pitfalls

Do gadolinium-enhanced MRI for young patients who have eye pain with movement and loss of vision (eg, decreased visual acuity or color vision, field defects) or an afferent pupillary defect.

Prognosis

Prognosis depends on the underlying condition. Most episodes resolve spontaneously, with return of vision in 2 to 3 mo. Most patients with a typical history of optic neuritis and no underlying systemic disease, such as a connective tissue disease, recover vision, but > 25% have a recurrence in the same eye or in the other eye. MRI is used to determine future risk of demyelinating disease.

Treatment

Corticosteroids

Corticosteroids are an option, especially if multiple sclerosis is suspected. Treatment with methylprednisolone (500 mg to 1000 mg IV once/day) for 3 days followed by prednisone (1 mg/kg po once/day) for 11 days may speed recovery, but ultimate vision results are no different from those with observation alone. IV corticosteroids have been reported to delay onset of multiple sclerosis for at least 2 yr. Treatment with oral prednisone alone does not improve vision outcome and may increase the rate of recurrent episodes. Low-vision aids (eg, magnifiers, large-print devices, talking watches) may be helpful. Other treatments, such as those used to treat multiple sclerosis, can be given if multiple sclerosis is suspected.

Key Points

Optic neuritis is most common among adults 20 to 40 yr.

The most common cause is multiple sclerosis, but infections, tumors, drugs, and toxins are other possible causes.

Was This Page Helpful?

Also of Interest

Chalazion and Hordeolum (Stye)

A 43-year-old female comes to the office reporting diffuse swelling of her eyelid that started 3 days ago, and now has localized to the body of the eyelid, where a small nontender nodule has developed. She has tearing, photophobia, and a foreign body sensation for the past 3 days. Given these symptoms, which diagnosis is most likely?

MONDAY, May 11, 2015 (HealthDay News) -- Age-related macular degeneration (AMD) is a predictor of poor survival, especially among women aged 80 years and older, according to a study published online May 4 in the Journal of the American Geriatrics Society .
Kathryn L. Pedula, from the Kaiser...

MONDAY, June 1, 2015 (HealthDay News) -- Changes in bacteria populations may be one reason why people who wear contact lenses are more prone to eye infections, a new study suggests. The findings were to be presented Sunday at the annual meeting of the American Society for Microbiology, held from...

Merck and the Merck Manuals

Merck & Co., Inc., Kenilworth, NJ, USA is a global healthcare leader working to help the world be well. From developing new therapies that treat and prevent disease to helping people in need, we are committed to improving health and well-being around the world. The Merck Manual was first published in 1899 as a service to the community. The legacy of this great resource continues as the Merck Manual in the US and Canada and the MSD Manual outside of North America. Learn more about our commitment to Global Medical Knowledge.